A Comparison Between Biportal and Uniportal Endoscopic Lumbar Discectomy

NCT ID: NCT07151651

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2027-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to provide a detailed comparison between different methods of lumbar discectomy by the use of different types of spine endoscopy to evaluate the benefits and drawbacks of each type

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to compare between uniportal and biportal endoscopic techniques in patients with lumbar disc herniation in terms of efficacy, safety, and learning curve of endoscopic spine surgery .The research will focus on clinical outcomes, functional recovery, complication rates, patient satisfaction and surgical proficiency in different endoscopic spine surgery techniques, including uniportal and biportal approaches assessing their relative advantages and limitations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

A prospective study will be conducted at Sohag and Cairo University Hospitals on 60 patients diagnosed with lumbar disc herniation, undergoing endoscopic lumbar discectomy.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with lumbar disc prolapse

1. Patients aged 18-70 years.
2. single-level lumbar disc herniation (L3-L4, L4-L5, or L5-S1) confirmed by MRI.
3. Persistent symptoms not responding to conservative management (≥6 weeks).

Group Type ACTIVE_COMPARATOR

Endoscopic lumbar discectomy

Intervention Type PROCEDURE

Uniportal and boportal endoscopic lumbar discectomy (transforaminal or interlaminar)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic lumbar discectomy

Uniportal and boportal endoscopic lumbar discectomy (transforaminal or interlaminar)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients should fulfill the following criteria

1. Patients aged 18-70 years.
2. single-level lumbar disc herniation (L3-L4, L4-L5, or L5-S1) confirmed by MRI.
3. Persistent symptoms not responding to conservative management (≥6 weeks).

Exclusion Criteria

* All patients should not have any of the following criteria

1. Multilevel disc herniation.
2. Previous lumbar spine surgery, trauma or injection.
3. Severe spinal stenosis.
4. Severe osteoporosis, infection, or malignancy or autoimmune disease affecting the spine.
5. Uncontrolled medical comorbidities contraindicating surgery.
6. Instability: spondylolisthesis\>grade 1
7. Marked obesity.(BMI \>35-40 kg/m2 )
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Ibraheem Amin

Assistant lecturer at neurosurgery department sohag University

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag University

Sohag, Sohag Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

mohamed Ibrahim Amin, Assesstant lecturer

Role: CONTACT

002 010 215 64439 ext. 010 215 64439

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sohag-Med-25-8---4MD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.